Skip to content

The Buzz About Sarepta Therapeutics’ Orphan Drug Eteplirsen For Duchenne Muscular Dystrophy: SeekingAlpha.com’s Perspective

October 8, 2012

         An October 8, 2012 SeekingAlpha.com article gives a detailed review & analysis of Sarepta Therapeutics’ orphan drug Eteplirsen for Duchenne Muscular Dystrophy (DMM).

References

Sarepta Therapeutics October 3, 2012 News Release

Orphan Druganaut September 10, 2012 Blog Post titled,”The Human Side Of an Orphan Drug”

Orphan Druganaut September 25, 2012 Blog Post titled,”The Power & Influence of Patient Advocacy Groups & Venture Philanthropy on Orphan Drug Development”

Copyright © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: